Email:
info@smallcellovarian.org
Home
Resources
Expand Your Knowledge
About Small Cell Ovarian Cancer
Common Symptoms
Possible Oncologist Questions
Articles & Information
Helpful Links
Research
Biology of the Disease
Treatment Research
Reviews on SCCOHT
Case Reports
Clinical Trials
SCCOHT Networks
SCCOHT Consortium
Patient Registry
Physicians Network
Support Us
SCOCF Store
Note Cards
Lapel Pins
Bookmarks
Donate to SCOCF
In Honor Of
Bookmark Campaign
Team Events
Upcoming Events
Past Events
Create A SCOCF Team
Our Story
Contact Us
DONATE
Case Reports
The articles below are listed in chronological order, newest to oldest.
A dramatic response to checkpoint inhibitor in a woman with small cell carcinoma of the hypercalcemic type of the ovary (J. Altmann W. Schmitt, N. Bashian, J. Sehouli)
Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Li & Jiang, 2022)
Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report (Coşkun et al., 2022)
Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition (Simões et al., 2022)
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult (Pressey et al., 2020)
Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type (Lee et al., 2020)
Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report (Mathey et al., 2020)
Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts (Connor et al., 2020)
Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach (Qin et al., 2018)
The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases (Foulkes et al., 2017)
Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type (Berchuck et al., 2015)
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type (Moes-Sosnowska et al., 2015)
Primary rhabdoid tumor of the ovary: When large cells become small cells (Rabinovich et al., 2015)
Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type. (Pressey et al., 2013)
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type (Stephens et al., 2012)
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary. (Wallbillich et al., 2012)
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy. (Kanwar et al., 2008)
Familial cluster of ovarian small cell carcinoma: a new mendelian entity? (Longy et al., 1996)
